A Phase 1 First-in-Human Study (B4901001) Evaluating a Novel Anti-IgE Vaccine in Adult Subjects with Allergic Rhinitis

Methods This was a randomized within cohort (total planned n=189 subjects), double-blinded, placebo controlled, dose ascending study to evaluate the safety, tolerability, immunogenicity and exploratory pharmacodynamic responses of the vaccine antigens (6, 20, 60 or 200 μg total) combined with fixed...

Full description

Bibliographic Details

Published in:	Journal of allergy and clinical immunology 2016-02, Vol.137 (2), p.AB164-AB164
Main Authors:	Wong, Gilbert Y., MD, Elfassi, Emile, MD, Girard, Ginette, MD, Yang, William H., MD, Hebert, Jacques, MD, Bugarini, Roberto, PhD, O'Connell, Michael A., MD, Champion, Brian, PhD, Merson, James, PhD, Davis, Heather, PhD
Format:	Article
Language:	English
Subjects:	Allergies Allergy and Immunology Aluminum Antigens Immunization Immunoglobulins
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!